Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.
2.

Safety of long-term treatment with HFA albuterol.

Ramsdell JW, Klinger NM, Ekholm BP, Colice GL.

Chest. 1999 Apr;115(4):945-51.

PMID:
10208190
3.

Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.

Bronsky E, Ekholm BP, Klinger NM, Colice GL.

J Asthma. 1999;36(1):107-14.

PMID:
10077140
4.

Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.

Barnes N, Price D, Colice G, Chisholm A, Dorinsky P, Hillyer EV, Burden A, Lee AJ, Martin RJ, Roche N, von Ziegenweidt J, Israel E.

Clin Exp Allergy. 2011 Nov;41(11):1521-32. doi: 10.1111/j.1365-2222.2011.03820.x. Epub 2011 Jul 14.

PMID:
21752116
5.

A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.

Langley SJ, Sykes AP, Batty EP, Masterson CM, Woodcock A.

Ann Allergy Asthma Immunol. 2002 May;88(5):488-93.

PMID:
12027070
6.

Clinical comparability of ventolin formulated with hydrofluoroalkane or conventional chlorofluorocarbon propellants in children with asthma.

Shapiro G, Bronsky E, Murray A, Barnhart F, VanderMeer A, Reisner C.

Arch Pediatr Adolesc Med. 2000 Dec;154(12):1219-25.

PMID:
11115306
7.

Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.

Ramsdell JW, Colice GL, Ekholm BP, Klinger NM.

Ann Allergy Asthma Immunol. 1998 Dec;81(6):593-9.

PMID:
9892032
8.

Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.

Chopra N, Williams M, Rimmer M, Kahl L, Jenkins M; SMO30006 and SMO30007 International Study Teams.

Respir Med. 2005 Apr;99 Suppl A:S1-S10. Epub 2005 Jan 26.

9.

Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.

Huchon G, Hofbauer P, Cannizzaro G, Iacono P, Wald F.

Eur Respir J. 2000 Apr;15(4):663-9.

10.

Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.

Hawksworth RJ, Sykes AP, Faris M, Mant T, Lee TH.

Ann Allergy Asthma Immunol. 2002 May;88(5):473-7.

PMID:
12027068
11.
12.
13.

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.

Bhattacharya A, Bhargava S, Singh V, Talwar D, Whig J, Rebello J, Purandare S, Gogtay J.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 30;11:1469-76. doi: 10.2147/COPD.S89923. eCollection 2016.

14.

Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.

Donnell D, Harrison LI, Ward S, Klinger NM, Ekholm BP, Cooper KM, Porietis I, McEwen J.

Eur J Clin Pharmacol. 1995;48(6):473-7.

PMID:
8582466
15.

The change to non-CFC metered dose inhalers.

Rubinfeld A.

Aust Fam Physician. 1997 Dec;26(12):1412-4.

PMID:
9470296
16.

Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Douglas G, Muers M, Smith D, White J.

Health Technol Assess. 2001;5(26):1-149. Review.

17.
18.

Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.

Lumry W, Noveck R, Weinstein S, Barnhart F, Vandermeer A, Murray A, Reisner C.

Ann Allergy Asthma Immunol. 2001 Mar;86(3):297-303.

PMID:
11289328
19.

Factors affecting the efficiency of aerosol therapy with pressurised metered-dose inhalers through plastic spacers.

Chuffart AA, Sennhauser FH, Wildhaber JH; Swiss Paediatric Respiratory Physiology Research Group.

Swiss Med Wkly. 2001 Jan 12;131(1-2):14-8.

PMID:
11205181
20.

Supplemental Content

Support Center